In medical breakthrough, a baby diagnosed with rare genetic disorder is thriving after customized CRISPR gene editing therapy ...

With a better upfront offer on the table, enough bluebird bio investors have tendered their shares for the company's sale to ...

Further, Editas Medicine has decreased expenses and costs thanks to discontinuing the development of reni-cel and laying off ...

KJ Muldoon came into the world with a genetic time bomb ticking inside him.

Beam Therapeutics faces slow pipeline progress and high R&D costs despite a $500M cash boost. Learn why patience is key for ...

Aligning with EU on genetically modified food and agricultural products will create a regulatory cliffedge for a sector which ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future ...

Methods A retrospective study of medical charts was performed to compare maternal and perinatal outcomes in Hb SS, Hb SC disease and sickle-beta thalassemia (Hb Sβ) pregnancies followed at a high-risk ...

Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...

One of the most common signs of thalassemia is tiredness. Children may seem more tired than other kids, even after a good ...